779 releases · Page 17

Health & Medicine

Latest press releases filed to this category.

All Of Me Wellness launches platform for women's health and support

All Of Me Wellness, a new online platform dedicated to women’s health, has officially launched, offering a comprehensive resource hub and supportive community for those navigating chronic pain and wellness. Founded by Jennifer Banmiller and Annie Jacoby, the platform aims …

SELLAS Life Sciences Group, Inc · 09.03 05:12 GMT

SELLAS Life Sciences Group to Present Preclinical Data on SLS009 at AACR Conference

NEW YORK, SELLAS Life Sciences Group, a late-stage clinical biopharmaceutical company, will present preclinical data on its drug candidate SLS009 (tambiciclib) at the 2026 AACR Conference on Pancreatic Cancer, held from September 25 to 28 at the Hilton San Diego …

ENvue Medical · 09.03 05:07 GMT

ENvue Medical to Showcase Real-Time Feeding Tube Placement Technology at Vizient Event

TYLER, Texas -- ENvue Medical, a company specializing in real-time guided bedside feeding tube placement, has been selected to showcase its ENvue™ Navigation Platform at the Vizient® Innovative Technology Exchange. The event, scheduled for September 24, …

09.03 04:02 GMT

How a Transaction of the Heart Can Change Your Life explores humanity's origin and purpose

David Wyatt Aiken, Jr., M.D., has released a new book, "How a Transaction of the Heart Can Change Your Life": Or Rocks, Water, and DNA, exploring humanity's origin and purpose through a Christian lens. Published by Christian Faith Publishing, the …

Amplio Spine, LLC · 09.03 03:38 GMT

Amplio Spine appoints TJ Jackson as Executive Vice President of Sales and Commercialization

Boca Raton, Fla., Amplio Spine, a commercial-stage medical-device company, has appointed TJ Jackson as Executive Vice President of Sales and Commercialization, effective immediately. Jackson's extensive experience in spine commercialization is expected to drive national growth for Amplio Spine's KeyLift® platform.

Hopelab · 09.03 03:35 GMT

Amy Green honored as 2026 Fierce 50 Health Equity honoree

SAN FRANCISCO -- Amy Green, Hopelab's Head of Research, has been honored as a 2026 Fierce 50 Health Equity honoree by Fierce Pharma, Fierce Biotech, and Fierce Healthcare. Now in its fourth year, the Fierce 50 …

Immunic, Inc · 09.03 03:25 GMT

Immunic appoints Chitrang Davé as Chief Data and Digital Officer

Immunic, Inc., a late-stage biotechnology company developing novel oral therapies for neurologic diseases, has announced the appointment of Chitrang Davé as Chief Data and Digital Officer (CDDO). Davé will report directly to Chief Executive Officer Erik Lundgren and join Immunic's …

Capricor Therapeutics, Inc · 09.03 03:03 GMT

Class action lawsuit filed against Capricor Therapeutics for alleged securities fraud

A leading securities law firm has announced that a class action lawsuit has been filed against Capricor Therapeutics, Inc. (NASDAQ: CAPR) and certain senior executives for alleged securities fraud following a significant drop in the …

Avricore Health Inc · 09.03 02:56 GMT

Avricore Health Expands Cholesterol Testing Program Nationally

VANCOUVER, British Columbia -- Avricore Health Inc. (TSXV: AVCR) has announced the national expansion of the Barts Health pharmacy cholesterol testing programme across England, powered by the company’s HealthTab™ platform. The initiative will roll out to …

Medtronic · 09.03 02:38 GMT

Medtronic invests $700M in Cornerstone Robotics to expand robotic surgery access

Global healthcare technology leader Medtronic has entered a strategic partnership with Cornerstone Robotics, a company dedicated to advancing minimally invasive surgery. The partnership involves an investment of approximately $700 million, granting Medtronic the rights to distribute Cornerstone Robotics’ Sentire™ surgical …

eCential Robotics · 09.03 02:27 GMT

eCential Robotics to join Enovis in Q4 2026

eCential Robotics, a leading developer of surgical robotics and enabling technologies, has secured a binding offer from Enovis Corporation, marking a significant expansion for both companies. The acquisition, expected to close in the fourth quarter of 2026, aligns with Enovis' …

MiniMed Inc · 09.03 02:19 GMT

MiniMed reports strong first quarter results with 17% net sales increase

MiniMed, a global leader in diabetes technology, announced robust financial results for the first quarter of fiscal year 2027, marking a significant start to its fiscal year. The company reported net sales of $843 million, a 17% increase from the …

Xentria, Inc · 09.03 01:41 GMT

Xentria Expands XAtlas Study for XTMAB-16 in Pulmonary Sarcoidosis

Xentria, Inc., a clinical-stage biotherapeutics company, has outlined its next steps for advancing XTMAB-16, an investigational anti-tumor necrosis factor alpha (TNFα) therapy for pulmonary sarcoidosis. The decision follows feedback from the U.S. Food and Drug Administration …

Unicycive Therapeutics, Inc · 09.03 01:24 GMT

Unicycive Therapeutics to Present Kidney Disease Therapies at Investment Conference

LOS ALTOS, Calif. -- Unicycive Therapeutics, a clinical-stage biotechnology company focused on developing therapies for kidney diseases, will present its latest advancements at the H.C. Wainwright 28th Annual Global Investment Conference. The company's chief executive officer, …

Ocugen, Inc · 09.03 01:19 GMT

Ocugen initiates global Phase 3 trial for gene therapy OCU410 in geographic atrophy

Ocugen, Inc. has announced the dosing of the first patient in a global Phase 3 trial for its gene therapy OCU410, designed to treat geographic atrophy (GA) secondary to dry age-related macular degeneration (dAMD). The trial, named ArMaDa3 (NCT07770828), is …

Invivyd, Inc · 09.03 01:14 GMT

Invivyd Appoints Marc Elia as New CEO to Lead Viral Infectious Disease Protection Efforts

NEW HAVEN, Conn., Invivyd, a biopharmaceutical company focused on delivering protection from serious viral infectious diseases, announced on September 1, 2026, that it has appointed Marc Elia, the current Chairman of the Invivyd Board of Directors, as its new Chief …

Tenax Therapeutics, Inc · 09.03 01:02 GMT

Tenax Therapeutics to Present at 2026 Cantor Global Healthcare Conference

CHAPEL HILL, N.C. -- Tenax Therapeutics, a Phase 3 development-stage pharmaceutical company, is set to participate in the upcoming 2026 Cantor Global Healthcare Conference. On September 9, 2026, at 8:35 a.m. Eastern Time, the company’s President …

Tango Therapeutics, Inc · 09.03 00:57 GMT

Tango Therapeutics to Participate in 2026 Cantor Global Healthcare Conference

BOSTON -- Tango Therapeutics, a clinical-stage biotechnology company focused on precision medicine for cancer treatment, will participate in a fireside chat at the 2026 Cantor Global Healthcare Conference on Wednesday, September 9, 2026, at 8:35 AM …

Seres Therapeutics, Inc · 09.03 00:55 GMT

Seres Therapeutics to Present at H.C. Wainwright Conference

CAMBRIDGE, Mass. -- Seres Therapeutics, a leading live biotherapeutics company, will participate in the H.C. Wainwright 28th Annual Global Investment Conference, to be held in New York on September 15, 2026. The company’s management will present …

Jade Biosciences, Inc · 09.03 00:50 GMT

Jade Biosciences to Participate in Several Industry Conferences

San Francisco and Vancouver, British Columbia, September 1, 2026, Jade Biosciences, Inc. (Nasdaq: JBIO), a clinical-stage biotechnology company focused on developing innovative therapies for autoimmune diseases, will participate in several upcoming industry conferences, providing insights into its pipeline and strategic …

Axogen, Inc · 09.03 00:48 GMT

Axogen to Participate in 24th Annual Morgan Stanley Global Healthcare Conference

Axogen, Inc., a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, will participate in the 24th Annual Morgan Stanley Global Healthcare Conference. The company's management will be available for one-on-one investor meetings …

09.03 00:47 GMT

Functional Medicine IS Longevity Medicine™ Masterclass Returns for 2026

The Functional Medicine IS Longevity Medicine™ Masterclass Returns to Redefine the Future of Healthspan …

Moderna, Inc · 09.03 00:42 GMT

Moderna to Present at Two Major Investor Conferences in September

On September 14 and 23, 2026, biotech giant Moderna, Inc. (Nasdaq: MRNA) will present at two major investor conferences. The company will participate in the Morgan Stanley 24th Annual Global Healthcare Conference on Monday, September 14, at 10:00 a.m. ET, …

Bionic Bloom Integrated Health · 09.03 00:38 GMT

Sarah Jameson Albrecht joins Bionic Bloom Integrated Health as a therapy provider

Bionic Bloom Integrated Health, a provider of integrated mental health and wellness services, has welcomed Sarah Jameson Albrecht, MS, to its team of therapy providers. Based in St. Petersburg, Albrecht brings a unique approach to counseling, focusing on trauma-informed, neurodivergent-affirming, …

American Academy of Cosmetic Medicine Inc · 09.03 00:34 GMT

AACM launches PRP & PRF Certification Program for medical professionals

The American Academy of Cosmetic Medicine (AACM) has introduced the AACM PRP & PRF Certification Program, the top choice for medical professionals seeking comprehensive, self-paced education in platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) therapies, at an affordable price of …

Ripley's Aquarium of Myrtle Beach · 09.03 00:32 GMT

Ripley's Aquarium Welcomes Five New African Penguin Chicks

At Ripley's Aquarium of Myrtle Beach, a recent arrival has brought an extra dose of joy and celebration. The aquarium welcomed an additional five African penguin chicks to its Penguin Playhouse, bringing the total number of chicks hatched this year …

ZEO ScientifiX Inc · 09.03 00:27 GMT

Inaugural ZEO Xperience Brings Regenerative Medicine Experts to Fort Lauderdale

Leading figures from various healthcare disciplines will converge in Fort Lauderdale, Florida, for the inaugural ZEO Xperience, a three-day regenerative medicine event scheduled for October 23-25, 2026.

Kazia Therapeutics Limited · 09.03 00:09 GMT

Kazia Therapeutics Expands Paxalisib Trial for HR+ Breast Cancer

Kazia Therapeutics, an oncology-focused biotechnology company, has expanded its clinical trial for paxalisib into hormone receptor-positive (HR+), HER2-negative (HER2-) breast cancer, following promising preclinical data. The expansion, which will evaluate paxalisib in combination with fulvestrant and palbociclib, aims to determine …

USANA Health Sciences · 09.02 23:54 GMT

USANA CEO Kevin Guest calls for intentional service in daily life

SALT LAKE CITY -- USANA Health Sciences Chairman and CEO Kevin Guest has issued a call to action, encouraging individuals to make service a more intentional part of their lives. Guest, who founded the company in …

Vera Therapeutics, Inc · 09.02 23:41 GMT

Vera Therapeutics to Present at Upcoming Investor Conferences

BRISBANE, Calif. -- Vera Therapeutics, a biotechnology company focused on autoimmune diseases, will participate in upcoming investor conferences to discuss its flagship product and future plans.

Alumis Inc · 09.02 23:40 GMT

Alumis Announces Topline Results from Envudeucitinib Phase 2b Trial in Systemic Lupus Erythematosus (SLE)

Alumis Inc., a late-stage biopharmaceutical company, announced today the results of its Phase 2b LUMUS trial for envudeucitinib, a next-generation, highly selective, oral allosteric inhibitor of tyrosine kinase 2 (TYK2), in the treatment of moderate-to-severe systemic lupus erythematosus (SLE). The …

Abeona Therapeutics Inc · 09.02 23:29 GMT

Abeona Therapeutics issues equity awards to attract new non-executive employees

CLEVELAND -- Abeona Therapeutics Inc., a biopharmaceutical company developing cell and gene therapies for serious diseases, has announced the issuance of equity awards to new non-executive employees as part of its hiring strategy. The awards, granted …

Keenova Therapeutics plc · 09.02 23:00 GMT

Keenova launches mixed reality program for National Hand Health Month

Keenova Therapeutics plc is launching its second annual National Hand Health Month (HHM) campaign, aimed at raising awareness about hand health and encouraging early detection of conditions such as Dupuytren's contracture. The campaign, which runs through September, will feature a …

Clearmind Medicine Inc · 09.02 22:52 GMT

Clearmind Medicine Initiates Phase IIa Trial for CMND-100 in AUD Treatment

Vancouver, Canada -- Clearmind Medicine Inc., a clinical-stage biopharmaceutical company based in the United States, has reached a significant milestone in its ongoing research for alcohol use disorder (AUD). The company announced the initiation of Phase …

NorthStrive Biosciences Inc · 09.02 22:01 GMT

NorthStrive Biosciences Expands AI-Driven Drug Discovery Program with Yuva Biosciences

NorthStrive Biosciences Inc., a subsidiary of PMGC Holdings Inc., has announced an expansion of its AI-driven drug discovery program with strategic partner Yuva Biosciences, Inc. The six-month program aims to narrow down four validated compounds towards the nomination of a …

Kala Bio Inc · 09.02 21:58 GMT

Kala Bio and Virotek sign distribution partnership for ophthalmology genetic testing

ARLINGTON, Mass. -- Kala Bio and Virotek Inc. have signed a letter of intent to establish an exclusive U.S. distribution partnership for Virotek's ophthalmology genetic testing and screening program. This collaboration aims to leverage Kala Bio's …

Black Book Research · 09.02 21:45 GMT

Black Book Research Identifies Three Key Investment Signals in Healthcare IT

Black Book Research, a leading global healthcare technology market-research firm, has identified three underreported investment signals that could significantly influence the valuation, deal structure, and competitive positioning of healthcare IT companies through 2029. The findings, detailed in the Q3 2026 …

Bausch Health Companies Inc · 09.02 21:18 GMT

Bausch Health expands Fraxel FTX® to Australia

Bausch Health has expanded its skin resurfacing technology to Australia, introducing the Fraxel FTX® to health care practitioners on September 1, 2026. This advanced device, part of the company’s Solta Medical division, builds upon more than two decades of innovation …

SmartConnect GmbH · 09.02 21:13 GMT

SmartConnect and Benepicks Partner to Integrate Medicare Support into ICHRA Platform

In a bid to address the complex healthcare challenges faced by the aging workforce, industry leaders SmartConnect and Benepicks have partnered to integrate Medicare support into their ICHRA (Health Reimbursement Arrangement) platform. This collaboration aims to eliminate the "Medicare cliff" …

Metagenomi Therapeutics, Inc · 09.02 20:49 GMT

Metagenomi Therapeutics to Present at Wells Fargo Healthcare Conference

EMERYVILLE, Calif. -- Metagenomi Therapeutics, Inc., an in vivo genome editing company, will present at the Wells Fargo 21st Annual Healthcare Conference in Boston, Massachusetts, on September 10, 2026. Jian Irish, Ph.D., M.B.A., the company’s President …

Talk to the desk

Questions before you file?

Volume pricing, corrections, partnerships — whatever doesn't fit a form field. Tell us what you need and we'll size it properly.